Detection of multiple activating NRAS variants under BRAF/MEK-inhibitor therapy in BRAF positive malignant melanoma using liquid biopsy

JAAD Case Rep. 2024 Jul 23:52:4-7. doi: 10.1016/j.jdcr.2024.06.036. eCollection 2024 Oct.

Authors

Frederike Hagedorn¹, Daniela Göppner², Sabrina Hartmann¹, Stefan Gattenlöhner¹, Andreas Bräuninger¹

Affiliations

¹ Institute of Pathology, University Hospital Giessen, Giessen, Germany.
² Department of Dermatology, University Hospital Giessen, Giessen, Germany.

No abstract available

Keywords: BRAF/MEK-inhibitor therapy; NRAS; liquid biopsy; melanoma.

Publication types

Case Reports